Z48.280

Clinical Causes: End-stage heart failure unresponsive to other treatments Severe lung diseases such as pulmonary fibrosis or cystic fibrosis Congenital heart and lung conditions requiring combined organ replacement Advanced pulmonary hypertension with associated heart failure Life-threatening conditions where combined organ transplant offers the best chance for survival

Key Symptoms: Rejection episodes characterized by fatigue, fever, and shortness of breath Signs of infection such as fever, chills, and malaise Organ dysfunction manifesting as persistent cough, chest pain, or swelling Symptoms of medication side effects including nausea, tremors, or weight changes General fatigue and weakness

Diagnosis Path: Monitoring after a heart-lung transplant involves regular clinical evaluations, imaging tests like chest X-rays, pulmonary function tests, and laboratory assessments. Blood tests help detect signs of organ rejection or infection, while biopsies of the transplanted organs can provide definitive evidence of rejection. A comprehensive follow-up plan typically includes various laboratory and imaging procedures tailored to each patient’s needs to ensure early detection of complications and maintain organ health.

Treatment Protocols: Post-transplant aftercare centers around immunosuppressive medications to prevent organ rejection, infection control, and managing side effects of medication. Patients may also receive additional treatments such as antibiotics for infections, medications for managing blood pressure or other comorbidities, and lifestyle counseling. The care team usually includes transplant specialists, cardiologists, pulmonologists, and transplant coordinators who work together to develop a personalized follow-up plan. Regular check-ups, medication adherence, and prompt reporting of symptoms are essential components of successful post-transplant management.